Meanwhile, the P2X7‐expressing TAMs in lung cancer are associated with anti‐PD‐1 antibody resistance, which can be overcome by P2X7 inhibitors O‐ATP, A‐740003, and A‐438079 hydrochloride. Here, P2RX7 is linked to lung carcinoma.